The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rates of pathologic complete response (pCR)after neoadjuvant datopotamab deruxtecan (Dato): Results from the I-SPY2.2 trial.
 
Jane Lowe Meisel
Honoraria - Medscape; Total Health Conferencing
Consulting or Advisory Role - AstraZeneca; Curio Science; GE Healthcare; Genentech; GlaxoSmithKline; Novartis; Olema Oncology; Pfizer; SeaGen
Research Funding - Olema Oncology (Inst); Pfizer; Seagen; Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Total Health Conferencing
 
Katia Khoury
No Relationships to Disclose
 
Amy Jo Chien
Research Funding - Amgen (Inst); Merck (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Pending Patent Application for “COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER”
 
Anne M. Wallace
Consulting or Advisory Role - Boston Scientific
 
Mili Arora
No Relationships to Disclose
 
Mariya Rozenblit
No Relationships to Disclose
 
Nicole Olivia Williams
Honoraria - NCCN; Total Health Conferencing
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; GE Healthcare; Gilead Sciences; Guardant Health; Merck; Moderna Therapeutics; Novartis; Sanofi; Seagen; Stemline Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Virginia F. Borges
Stock and Other Ownership Interests - Perla THerapeutics
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Seagen
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Olema Oncology (Inst); Seagen (Inst)
 
Erica Michelle Stringer-Reasor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Merck; Merck; Novartis; Pumas-AI; Pumas-AI; Seagen
Research Funding - Susan G. Komen for the Cure; V Foundation
 
Judy Caroline Boughey
Honoraria - PeerView; PER; UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
Travel, Accommodations, Expenses - Endomagnetics; Endomagnetics
 
Chaitali Nangia
Honoraria - Gilead Sciences; Lilly; Regeneron; Stemline Therapeutics
Consulting or Advisory Role - Gilead Sciences; Lilly; Regeneron; Stemline Therapeutics
Speakers' Bureau - Gilead Sciences; Regeneron; Stemline Therapeutics
Travel, Accommodations, Expenses - Gilead Sciences; Regeneron; Stemline Therapeutics
 
Christos Vaklavas
Employment - Flatiron Health (I)
Honoraria - Cardinal Health; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Guidepoint Global; Novartis; Pfizer; Pfizer; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences
Research Funding - AstraZeneca (Inst); AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); H3 Biomedicine (Inst); Incyte (Inst); Innocrin Pharma (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Seagen (Inst); TRACON Pharma (Inst); Zymeworks (Inst)
Other Relationship - Daiichi Sankyo; Puma Biotechnology; Takeda
(OPTIONAL) Uncompensated Relationships - Genentech
 
Laura van 't Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia; Exai Bio
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Nola Hylton
Research Funding - Siemens Healthineers (Inst)
 
Douglas Yee
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Martell diagnostic
Research Funding - Boehringer Ingelheim
 
Christina Yau
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 63/314,065 (Inst); U.S. Provisional Application No. 63/341,579 (Inst)
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Moderna Therapeutics (Inst)
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative